745 related articles for article (PubMed ID: 12428808)
1. Tau and axonopathy in neurodegenerative disorders.
Higuchi M; Lee VM; Trojanowski JQ
Neuromolecular Med; 2002; 2(2):131-50. PubMed ID: 12428808
[TBL] [Abstract][Full Text] [Related]
2. Retarded axonal transport of R406W mutant tau in transgenic mice with a neurodegenerative tauopathy.
Zhang B; Higuchi M; Yoshiyama Y; Ishihara T; Forman MS; Martinez D; Joyce S; Trojanowski JQ; Lee VM
J Neurosci; 2004 May; 24(19):4657-67. PubMed ID: 15140937
[TBL] [Abstract][Full Text] [Related]
3. Brief update on different roles of tau in neurodegeneration.
Ittner A; Ke YD; van Eersel J; Gladbach A; Götz J; Ittner LM
IUBMB Life; 2011 Jul; 63(7):495-502. PubMed ID: 21698753
[TBL] [Abstract][Full Text] [Related]
4. Early axonopathy preceding neurofibrillary tangles in mutant tau transgenic mice.
Leroy K; Bretteville A; Schindowski K; Gilissen E; Authelet M; De Decker R; Yilmaz Z; Buée L; Brion JP
Am J Pathol; 2007 Sep; 171(3):976-92. PubMed ID: 17690183
[TBL] [Abstract][Full Text] [Related]
5. A brain-penetrant triazolopyrimidine enhances microtubule-stability, reduces axonal dysfunction and decreases tau pathology in a mouse tauopathy model.
Zhang B; Yao Y; Cornec AS; Oukoloff K; James MJ; Koivula P; Trojanowski JQ; Smith AB; Lee VM; Ballatore C; Brunden KR
Mol Neurodegener; 2018 Nov; 13(1):59. PubMed ID: 30404654
[TBL] [Abstract][Full Text] [Related]
6. Transgenic zebrafish model of neurodegeneration.
Tomasiewicz HG; Flaherty DB; Soria JP; Wood JG
J Neurosci Res; 2002 Dec; 70(6):734-45. PubMed ID: 12444595
[TBL] [Abstract][Full Text] [Related]
7. Ultrastructural neuronal pathology in transgenic mice expressing mutant (P301L) human tau.
Lin WL; Lewis J; Yen SH; Hutton M; Dickson DW
J Neurocytol; 2003 Nov; 32(9):1091-105. PubMed ID: 15044841
[TBL] [Abstract][Full Text] [Related]
8. Epothilone D improves microtubule density, axonal integrity, and cognition in a transgenic mouse model of tauopathy.
Brunden KR; Zhang B; Carroll J; Yao Y; Potuzak JS; Hogan AM; Iba M; James MJ; Xie SX; Ballatore C; Smith AB; Lee VM; Trojanowski JQ
J Neurosci; 2010 Oct; 30(41):13861-6. PubMed ID: 20943926
[TBL] [Abstract][Full Text] [Related]
9. Staging of neurofibrillary degeneration caused by human tau overexpression in a unique cellular model of human tauopathy.
Hall GF; Lee VM; Lee G; Yao J
Am J Pathol; 2001 Jan; 158(1):235-46. PubMed ID: 11141497
[TBL] [Abstract][Full Text] [Related]
10. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
11. Tau phosphorylation in neuronal cell function and dysfunction.
Johnson GV; Stoothoff WH
J Cell Sci; 2004 Nov; 117(Pt 24):5721-9. PubMed ID: 15537830
[TBL] [Abstract][Full Text] [Related]
12. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease.
Terwel D; Dewachter I; Van Leuven F
Neuromolecular Med; 2002; 2(2):151-65. PubMed ID: 12428809
[TBL] [Abstract][Full Text] [Related]
13. Studying Microtubule Dynamics in Human Neurons: Two-Dimensional Microtubule Tracing and Kymographs in iPSC- and SH-SY5Y-Derived Neurons for Tau Research.
Allroggen N; Breuer H; Bachmann S; Bell M; Zempel H
Methods Mol Biol; 2024; 2754():561-580. PubMed ID: 38512690
[TBL] [Abstract][Full Text] [Related]
14. What mechanisms of tau protein transport could be responsible for the inverted tau concentration gradient in degenerating axons?
Kuznetsov IA; Kuznetsov AV
Math Med Biol; 2017 Mar; 34(1):125-150. PubMed ID: 27034421
[TBL] [Abstract][Full Text] [Related]
15. Tau and Axonal Transport Misregulation in Tauopathies.
Combs B; Mueller RL; Morfini G; Brady ST; Kanaan NM
Adv Exp Med Biol; 2019; 1184():81-95. PubMed ID: 32096030
[TBL] [Abstract][Full Text] [Related]
16. [Neuropathology of tauopathy].
Yoshida M
Brain Nerve; 2013 Dec; 65(12):1445-58. PubMed ID: 24323931
[TBL] [Abstract][Full Text] [Related]
17. Microtubule-associated protein tau in development, degeneration and protection of neurons.
Wang JZ; Liu F
Prog Neurobiol; 2008 Jun; 85(2):148-75. PubMed ID: 18448228
[TBL] [Abstract][Full Text] [Related]
18. Microtubule dynamics and the neurodegenerative triad of Alzheimer's disease: The hidden connection.
Brandt R; Bakota L
J Neurochem; 2017 Nov; 143(4):409-417. PubMed ID: 28267200
[TBL] [Abstract][Full Text] [Related]
19. Changed conformation of mutant Tau-P301L underlies the moribund tauopathy, absent in progressive, nonlethal axonopathy of Tau-4R/2N transgenic mice.
Terwel D; Lasrado R; Snauwaert J; Vandeweert E; Van Haesendonck C; Borghgraef P; Van Leuven F
J Biol Chem; 2005 Feb; 280(5):3963-73. PubMed ID: 15509565
[TBL] [Abstract][Full Text] [Related]
20. Drosophila models of human tauopathies indicate that Tau protein toxicity in vivo is mediated by soluble cytosolic phosphorylated forms of the protein.
Feuillette S; Miguel L; Frébourg T; Campion D; Lecourtois M
J Neurochem; 2010 May; 113(4):895-903. PubMed ID: 20193038
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]